Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023

• Päätekijät: Dana E. Moseson (Tekijä), Trong Bien Tran (Tekijä), Bharathi Karunakaran (Tekijä), Rohan Ambardekar (Tekijä), Tze Ning Hiew (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Forty-eight (48) drug products (DPs) containing amorphous solid dispersions (ASDs) have been approved by the U.S. Food and Drug Administration in the 12-year period between 2012 and 2023. These DPs comprise 36 unique amorphous drugs. Ten (10) therapeutic categories are represented, with most DPs con...